Impact of Negative Symptom Domains and Other Clinical Characteristics on Functional Outcomes in Patients with Schizophrenia

Table 1

Demographic information.

Variable	Mean (SD)
Age (years)	47.3 (12.3)
Years of education	12.3 (1.6)
Male sex (%)	38.0
Assisted living (%)	51
Duration of illness	18.2 (11)
Previous hospitalizations	1.6 (2.3)
Antipsychotic medication dose^a (mg)	497.8 (359.6)
BNSS anhedonia	6.1 (4.5)
BNSS asociality	4.3 (2.7)
BNSS avolition	3.7 (2.6)
BNSS blunted affect	4.7 (4.1)
BNSS alogia	3.3 (3.5)
BPRS positive	6.4 (5.3)
SCoRS	38.5 (11.2)
EBS negative self-evaluations	16.4 (6.5)
EBS negative other–self evaluations	15.4 (6.0)
EBS negative self–other evaluations	11.2 (4.3)
SFS withdrawal	9.9 (2.7)
SFS interpersonal relationships	7 (5.3)
SFS social participation	7.4 (7.0)
SFS recreation	16.1 (7.5)
SFS self-reliance and execution	24.66 (8.5)
SFS employment	4.5 (3.6)

^aChlorpromazine conversion. BPRS: Brief Psychiatric Rating Scale; BNSS: Brief Negative Symptom Scale; EBS: Evaluative Beliefs Scale; SCoRS: Schizophrenia Cognition Rating Scale; SFS: Social Functioning Scale.